Charlene Mantia

13PUBLICATIONS
131CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 07, 2026
Functional epigenomic liquid biopsy identifies potential therapeutic vulnerabilities after enfortumab vedotin-pembrolizumab resistance in metastatic urothelial carcinoma (mUC).

|Aug 21, 2026
Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity.

|Feb 27, 2026
A small-molecule inverse agonist of PPARγ for advanced solid tumors: a phase 1 trial.

Matthew D Galsky, Charlene Mantia, Michaela Bowden

|Jan 30, 2026
Partitioned overall survival: comprehensive analysis of survival states over 4 years in CheckMate 9ER comparing first-line nivolumab plus cabozantinib versus sunitinib in advanced renal cell carcinoma.

Hollis Viray, Charlene M Mantia, Opeyemi A Jegede

|Jan 26, 2026
ctDNA Dynamics and Recurrence Patterns after Organ-Sparing Trimodality Therapy for Bladder Cancer.

Ilana B Epstein, Adetolani Odogiyon, Stephanie Berg

|Jan 12, 2026
Integrative Clinical and Molecular Evaluation of Renal Cell Carcinoma with Merlin Protein Deficiency and Biallelic Loss of NF2.

Emre Yekedüz, Weiwei Bian, Stephanie E Siegmund

Pageof 3

Frequent Collaborators

5 joint publications

Toni K Choueiri

4 joint publications

Meredith M Regan

4 joint publications

Michael B Atkins

4 joint publications

Bradley McGregor